Form 4: Medtronic EVP Sean Salmon Reports Stock Transactions
SEC Form 4 Filing
EVP & President Cardiovascular of Medtronic, Sean Salmon, reports the acquisition and disposal of ordinary shares and performance share units on August 2, 2024.
Summary
- Sean Salmon, EVP & President Cardiovascular at Medtronic, reported transactions involving Medtronic plc ordinary shares and performance share units on August 2, 2024.
- He acquired 5,462 ordinary shares upon the settlement of performance-vesting restricted stock units.
- 657 shares were withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024.
- 2,779 shares were withheld for taxes upon the vesting of restricted stock units previously reported.
- Following these transactions, Salmon beneficially owns 65,110 ordinary shares.
- 5,462 Performance share units vested on August 2, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and ownership positions in the company.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.
Key Dates
| Date | Description |
|---|---|
| 08/02/2021 | Date of grant for performance-vesting restricted stock units that settled on August 2, 2024. |
| 08/02/2024 | Date of transactions: acquisition and disposal of shares and vesting of performance share units. |
| 08/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.